News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,290 Results
Type
Article (1971)
Company Profile (76)
Press Release (71243)
Section
Business (32024)
Career Advice (50)
Deals (4980)
Drug Delivery (4)
Drug Development (7996)
Employer Resources (9)
FDA (1510)
Job Trends (1986)
News (44655)
Policy (2568)
Tag
Academia (115)
Accelerated approval (2)
Adcomms (1)
Allergies (18)
Alliances (2621)
ALS (18)
Alzheimer's disease (230)
Antibody-drug conjugate (ADC) (24)
Approvals (1558)
Artificial intelligence (92)
Autoimmune disease (10)
Automation (8)
Bankruptcy (17)
Best Places to Work (2060)
Biosimilars (23)
Biotechnology (49)
Bladder cancer (44)
Brain cancer (4)
Breast cancer (129)
Cancer (863)
Cardiovascular disease (33)
Career advice (47)
Career pathing (2)
CAR-T (25)
Cell therapy (99)
Cervical cancer (9)
Clinical research (7850)
Collaboration (278)
Compensation (192)
COVID-19 (181)
CRISPR (10)
C-suite (65)
Cystic fibrosis (17)
Data (749)
Depression (8)
Diabetes (59)
Diagnostics (800)
Digital health (6)
Diversity, equity & inclusion (3)
Drug discovery (21)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (29254)
Editorial (1)
Employer branding (1)
Employer resources (9)
Events (7999)
Executive appointments (270)
FDA (1997)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (272)
Gene editing (23)
Generative AI (2)
Gene therapy (71)
GLP-1 (103)
Government (332)
Grass and pollen (2)
Guidances (116)
Healthcare (2358)
Huntington's disease (3)
IgA nephropathy (8)
Immunology and inflammation (15)
Indications (9)
Infectious disease (221)
Inflammatory bowel disease (20)
Influenza (13)
Intellectual property (21)
Interviews (6)
IPO (3866)
IRA (1)
Job creations (206)
Job search strategy (42)
Kidney cancer (4)
Labor market (6)
Layoffs (24)
Legal (389)
Liver cancer (15)
Lung cancer (129)
Lymphoma (62)
Machine learning (2)
Management (2)
Manufacturing (62)
MASH (17)
Medical device (1759)
Medtech (1759)
Mergers & acquisitions (1365)
Metabolic disorders (134)
Multiple sclerosis (23)
NASH (3)
Neurodegenerative disease (21)
Neuropsychiatric disorders (2)
Neuroscience (351)
NextGen: Class of 2025 (539)
Non-profit (288)
Now hiring (1)
Obesity (59)
Opinion (9)
Ovarian cancer (24)
Pain (17)
Pancreatic cancer (19)
Parkinson's disease (39)
Partnered (1)
Patents (55)
Patient recruitment (29)
Peanut (10)
People (2320)
Pharmaceutical (20)
Phase I (1796)
Phase II (3019)
Phase III (3543)
Pipeline (730)
Policy (2)
Postmarket research (344)
Preclinical (554)
Press Release (2)
Prostate cancer (41)
Psychedelics (1)
Radiopharmaceuticals (26)
Rare diseases (71)
Real estate (239)
Recruiting (3)
Regulatory (2227)
Reports (4)
Research institute (121)
Resumes & cover letters (4)
Rett syndrome (5)
RSV (12)
Schizophrenia (19)
Series A (42)
Series B (35)
Service/supplier (1)
Sickle cell disease (12)
Special edition (1)
Spinal muscular atrophy (9)
Startups (133)
Stomach cancer (1)
Supply chain (24)
The Weekly (1)
Vaccines (94)
Venture capitalists (1)
Weight loss (24)
Women's health (6)
Worklife (2)
Date
Today (94)
Last 7 days (452)
Last 30 days (1259)
Last 365 days (9993)
2025 (4545)
2024 (7610)
2023 (5843)
2022 (6767)
2021 (7109)
2020 (6282)
2019 (4804)
2018 (3479)
2017 (3044)
2016 (2473)
2015 (3119)
2014 (2166)
2013 (1425)
2012 (1468)
2011 (2204)
2010 (1694)
Location
Africa (44)
Alabama (6)
Alaska (1)
Arizona (14)
Arkansas (4)
Asia (3896)
Australia (546)
California (2300)
Canada (486)
China (120)
Colorado (100)
Connecticut (145)
Delaware (100)
Europe (10223)
Florida (251)
Georgia (55)
Idaho (4)
Illinois (180)
India (6)
Indiana (68)
Iowa (4)
Japan (80)
Kansas (16)
Kentucky (4)
Louisiana (5)
Maine (15)
Maryland (217)
Massachusetts (1706)
Michigan (58)
Minnesota (120)
Mississippi (1)
Missouri (24)
Montana (4)
Nebraska (2)
Nevada (11)
New Hampshire (19)
New Jersey (636)
New Mexico (3)
New York (550)
North Carolina (263)
North Dakota (1)
Northern California (949)
Ohio (50)
Oklahoma (3)
Oregon (6)
Pennsylvania (364)
Puerto Rico (1)
Rhode Island (4)
South America (83)
South Carolina (2)
Southern California (810)
Tennessee (42)
Texas (321)
United States (7814)
Utah (51)
Virginia (57)
Washington D.C. (16)
Washington State (228)
West Virginia (1)
Wisconsin (45)
73,290 Results for "39".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Merck KGaA Moves Ahead on SpringWorks Buy for $3.9B
The transaction is expected to close in the second half of 2025. With the deal, Merck KGaA is adding to its rare disease and oncology pipelines.
April 28, 2025
·
3 min read
·
Tristan Manalac
Press Releases
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
May 12, 2025
·
9 min read
Press Releases
Precision Medicine Surge: KFSHRC Achieves 39% Rise in Genetic Mutation Analysis
March 20, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
April 1, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
March 31, 2025
·
6 min read
Press Releases
PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need
May 7, 2025
·
3 min read
Press Releases
Biopharmaceutical CMO and CRO Market Size to Worth USD 72.39 Bn by 2034
February 6, 2025
·
1 min read
Press Releases
Cell Therapy Market Size Uplifts USD 44.39 Bn at 22.69% Healthy CAGR by 2034
February 14, 2025
·
1 min read
Press Releases
Bipolar Disorder Market Size to Reach USD 3.9 Billion by 2035, Impelled by Improved Diagnosis and Early Intervention
Bipolar Disorder Market Outlook 2025-2035:
February 19, 2025
·
9 min read
Press Releases
Pneumonia Market Expected to Grow at a CAGR of 5.39% during 2025-2035. Impelled by Increasing Healthcare Expenditure & Access to Treatment
February 14, 2025
·
9 min read
1 of 7,329
Next
